On the value of large multicenter drug intervention trials

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 8, 1997, Pages 985-989

  Demol, Pierre ^a   Hübner, Günter E ^a   Weihrauch, Thomas R ^a  

^a BAYER AG   (Germany)

Author keywords

Bayotensin ; Baypress ; CAS 39562 70 4; Composite end points; Hard end points; Multicenter intervention trials; Nitrendipine; Pharmacoeconomy; Risk benefit ratio

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ENALAPRIL; FIBRINOLYTIC AGENT; HYDROCHLOROTHIAZIDE; NITRENDIPINE; PLACEBO; PRAVASTATIN; RETEPLASE; SIMVASTATIN; STREPTOKINASE;

ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG SCREENING; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; ORAL DRUG ADMINISTRATION; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ANTILIPEMIC AGENTS; CARDIOVASCULAR AGENTS; HUMANS; MULTICENTER STUDIES; RESEARCH DESIGN;

EID: 0030834137     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Topol, E. J., Califf, R. M., Br. Heart J. 68, 348 (1992)
2. The GUSTO Investigators, N. Engl. J. Med. 329, 673 (1993)
3. Demol, P., Weihrauch, T. R., Med. Klinik 92, 117 (1997)
4. Fletcher, R. H., Editorial, JAMA 262, 1842 (1989)
5. Antman, E. M., Califf, R. M., in: Cardiovascular Therapeutics, 1st ed., T. W. Smith (ed.), pp. 678-695, Saunders, New York (1996)
6. Mellies, M., McGovern, M., Exp. Opin. Invest. Drugs 6, 31 (1997)
7. TIMI Study Group, N. Engl. J. Med. 312, 932 (1985)
8. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardio (GISSI), Lancet I, 397 (1986)
9. ISIS-2 (Second International Study of Infact Survival) Collaborative Group, Lancet II, 349 (1988)
10. GISSI-2, Lancet 336, 65 (1990)
11. ISIS-3 Collaborative Group, Lancet 339, 753 (1992)
12. Bleich, S. S., Nichols, T. C., Schumacher, R. R. et al., Am. J. Cardiol. 66, 1412 (1990)
13. Neuhaus, K. L., Feuerer, W., Jeep-Teble, S. et al., J. Am. Coll. Cardiol. 14, 1566 (1989)
14. Mark, D. B., Hlatky, M. A., Califf, R. M. et al., N. Engl. J. Med. 332, 1418 (1995)
15. Mark, D. B., Pharmacoeconomics 9, 473 (1996)
16. Braunwald, E., Cannon, C. P., McCabe, C. H., Am. J. Cardiol. 72, 3G (1993)
17. Lee, L. V., Am. J. Cardiol. 75, 7 (1995)
18. Topol, E. J., Fuster, V., Califf, R. M. et al., Circulation 89, 1557 (1994)
19. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators, Circulation 90, 1631 (1994)
20. The GUSTO lib Investigators, N. Engl. J. Med. 335, 775 (1996)
21. Hampton, J. R., Eur. Heart J. 17 (Suppl. E), 28 (1996)
22. Scandinavian Simvastatin Survival Study, Lancet 344, 1383 (1994)
23. Shepherd, J., Cobbe, S. M., Ford, I. et al., N. Engl. J. Med. 333, 1301 (1995)
24. Amery, A., Birkenhäger, W., Bulpitt, C. J. et al., Aging 3, 287 (1991)
25. Staessen, J., Thijs, L., Mancia, G. et al., Lancet 344, 1552 (1994)
26. Staessen, J. A., Arabidze, G. G., Birkenhäger, W. H. et al., in preparation -
27. Reckless, J. P. D., Pharmacoeconomics 9, 101 (1996)
28. Detsky, A. S., JAMA 262, 1795 (1989)
29. Bucher, H., Weinbacher, M., Gyr, K., Br. Med. J. 309, 761 (1994)
30. Naylor, C., Chen, E., Strauss, B., Ann. Intern. Med. 117, 916 (1992)
31. Guyatt, G., Cook, D., Jaeschke, R., ACP J. Club 122, A12 (1995)
32. Lamas, G., Pfeffer, M., Hamm, P. et al., N. Engl. J. Med. 327, 241 (1992)
33. Fredrickson, D. S., Bull. N. Y. Acad. Med. 44, 985 (1968)
34. Epstein, R. S., Sherwood, L. M., Ann. Intern. Med. 124, 832 (1996)